Management of Elevated PSA Levels

Assessment and Diagnosis

A PSA value greater than 4.0 ng/ml has been the standard indication for prostate biopsy since the introduction of this test, despite recent discussions about potentially lowering this threshold 1
Although the PSA has remained stable over one year, the elevated PSA level of 6 ng/ml still presents a significant risk for underlying prostate cancer 2
The American College of Physicians and other medical societies recommend a prostate biopsy to rule out prostate cancer for men with a PSA level above 4.0 ng/ml, as this threshold is associated with an increased risk of prostate cancer 1, 2

Perform a prostate biopsy to definitively rule out prostate cancer, as the PSA level of 6 ng/ml exceeds the standard threshold of 4.0 ng/ml 1, 2
Conduct a thorough digital rectal examination (DRE) before the biopsy to assess for any palpable abnormalities that might have been missed 2
Continue regular PSA monitoring every 3-6 months for the first year, then every 6 months thereafter, as recommended by the British Journal of Cancer guidelines 3, 4
Perform digital rectal examination at each follow-up visit, as recommended by the British Journal of Cancer guidelines 4, 2
Consider repeat biopsy if there is any significant change in PSA (increase of 1.0 ng/ml or more in a year) or if DRE becomes abnormal, based on guidelines from the New England Journal of Medicine 1, 5